Dosing and efficacy in specific immunotherapy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue SUPPL. 95, 2011, Pages 38-40

  Demoly, Pascal ^a   Calderon, M A ^b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Allergen specific immunotherapy; dose response; dose effect relationship; optimisation with adjuvant

Indexed keywords

ALLERGIC RHINITIS; ARTICLE; DOSE RESPONSE; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RHINOCONJUNCTIVITIS; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; INJECTIONS, SUBCUTANEOUS; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 79958792123     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2011.02631.x     Document Type: Article

References (9)

1. Bousquet J, Lockey R, Malling HJ,. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102: 558-562.
2. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al., Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 86 (63 Suppl): 8-160. (Pubitemid 351357811)
3. Cox L, Jacobsen L,. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Ann Allergy Asthma Immunol 2009; 103: 451-459.
4. Calderõn MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P,. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol 2011; 127: 30-38.
5. Committee for Medicinal Products for Human Use. Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases 2008.
6. Johnstone DE, Crump L,. Value of hyposensitization therapy for perennial bronchial asthma in children. Pediatrics 1961; 27: 39-44.
7. Frew AJ, Powell RJ, Corrigan CJ, Durham SR,. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 319-325. (Pubitemid 43190146)
8. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S,. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 802-809.
9. Didier A, Malling HJ, Worm M, Horak F, Jager S, Montagut A, et al., Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007; 120: 1338-1345. (Pubitemid 350225683)